Literature DB >> 6766176

The in vivo differentiation of strains of yellow fever virus in mice.

R Fitzgeorge, C J Bradish.   

Abstract

Strains of yellow fever virus isolated since 1927 in Africa and the Americas, and strains derived from them, have been differentiated by the responses of mice of different ages to intraperitoneal (i.p.) or intracerebral (i.c.) infection. Infection, antibody conversion, protection and death have been presented on age-dose response phase diagrams that serve as in vivo 'fingerprints' for the differentiation of virus strains and their modifications through passage and selection. Correlations between marker characteristics are discussed in terms of the efficiency of infection, regulatory (pre-challenge) and protective (post-challenge) immunity, and the expression of virulence. The requirement in virus strain specification for the resolution of events on pathogenic and immunogenic pathways is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766176     DOI: 10.1099/0022-1317-46-1-1

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  18 in total

1.  Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease.

Authors:  Matthew Frieman; Boyd Yount; Sudhakar Agnihothram; Carly Page; Eric Donaldson; Anjeanette Roberts; Leatrice Vogel; Becky Woodruff; Diana Scorpio; Kanta Subbarao; Ralph S Baric
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system.

Authors:  Lauren N Luethy; Andrea K Erickson; Palmy R Jesudhasan; Mine Ikizler; Terence S Dermody; Julie K Pfeiffer
Journal:  Virology       Date:  2015-10-16       Impact factor: 3.616

3.  Dynamic viral dissemination in mice infected with yellow fever virus strain 17D.

Authors:  Andrea K Erickson; Julie K Pfeiffer
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

4.  Comparative immunochemical and biological analysis of African and South American yellow fever viruses.

Authors:  V Deubel; J J Schlesinger; J P Digoutte; M Girard
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Size heterogeneity in the 3' noncoding region of South American isolates of yellow fever virus.

Authors:  Juliet E Bryant; Pedro F C Vasconcelos; Rene C A Rijnbrand; J P Mutebi; Stephen Higgs; Alan D T Barrett
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

6.  Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone.

Authors:  T J Chambers; M Nickells
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model.

Authors:  Janice Nickells; Maria Cannella; Deborah A Droll; Yan Liang; William S M Wold; Thomas J Chambers
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

8.  Current Assessment of Yellow Fever and Yellow Fever Vaccine.

Authors:  Anabelle Lefeuvre; Philippe Marianneau; Vincent Deubel
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

9.  Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice.

Authors:  Michael Nickells; Thomas J Chambers
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.